A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,080 shares of CRSP stock, worth $142,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,080
Previous 2,535 21.5%
Holding current value
$142,573
Previous $136,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$44.62 - $62.75 $24,317 - $34,198
545 Added 21.5%
3,080 $144,000
Q2 2024

Jul 30, 2024

SELL
$51.17 - $68.18 $8.39 Million - $11.2 Million
-164,011 Reduced 98.48%
2,535 $136,000
Q1 2024

May 01, 2024

BUY
$60.67 - $89.12 $4.67 Million - $6.87 Million
77,053 Added 86.1%
166,546 $11.4 Million
Q4 2023

Jan 24, 2024

SELL
$38.62 - $72.18 $3.68 Million - $6.88 Million
-95,361 Reduced 51.59%
89,493 $5.6 Million
Q3 2023

Oct 26, 2023

BUY
$45.39 - $59.0 $783,340 - $1.02 Million
17,258 Added 10.3%
184,854 $8.39 Million
Q2 2023

Aug 10, 2023

SELL
$43.47 - $67.77 $155,231 - $242,006
-3,571 Reduced 2.09%
167,596 $9.41 Million
Q1 2023

May 04, 2023

BUY
$41.0 - $56.12 $310,165 - $424,547
7,565 Added 4.62%
171,167 $7.74 Million
Q4 2022

Feb 09, 2023

SELL
$39.19 - $65.67 $202,729 - $339,710
-5,173 Reduced 3.07%
163,602 $6.65 Million
Q3 2022

Nov 10, 2022

BUY
$61.1 - $83.78 $1.27 Million - $1.75 Million
20,829 Added 14.08%
168,775 $11 Million
Q2 2022

Jul 26, 2022

BUY
$43.23 - $73.83 $1.84 Million - $3.14 Million
42,564 Added 40.39%
147,946 $8.99 Million
Q1 2022

May 10, 2022

SELL
$53.19 - $79.24 $1.02 Million - $1.51 Million
-19,095 Reduced 15.34%
105,382 $6.62 Million
Q4 2021

Feb 08, 2022

BUY
$70.09 - $111.29 $2.51 Million - $3.99 Million
35,829 Added 40.42%
124,477 $9.43 Million
Q3 2021

Nov 15, 2021

BUY
$110.2 - $156.64 $1.89 Million - $2.68 Million
17,119 Added 23.93%
88,648 $9.92 Million
Q2 2021

Aug 11, 2021

BUY
$100.84 - $161.89 $4,739 - $7,608
47 Added 0.07%
71,529 $11.6 Million
Q1 2021

May 13, 2021

BUY
$110.72 - $210.04 $3.54 Million - $6.72 Million
32,015 Added 81.12%
71,482 $8.71 Million
Q4 2020

Feb 10, 2021

BUY
$79.67 - $173.23 $30,354 - $66,000
381 Added 0.97%
39,467 $6.04 Million
Q3 2020

Nov 12, 2020

BUY
$78.5 - $100.64 $981,721 - $1.26 Million
12,506 Added 47.05%
39,086 $3.27 Million
Q2 2020

Aug 11, 2020

BUY
$38.5 - $76.05 $550,896 - $1.09 Million
14,309 Added 116.61%
26,580 $1.95 Million
Q1 2020

May 12, 2020

BUY
$33.68 - $62.53 $44,356 - $82,352
1,317 Added 12.02%
12,271 $520,000
Q4 2019

Feb 12, 2020

BUY
$36.68 - $73.13 $61,989 - $123,589
1,690 Added 18.24%
10,954 $667,000
Q3 2019

Nov 12, 2019

BUY
$40.99 - $52.56 $379,731 - $486,915
9,264 New
9,264 $380,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.